225 studies found for:    Open Studies | "Cystic Fibrosis"
Show Display Options
Rank Status Study
1 Recruiting Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)
Conditions: Cystic Fibrosis Related Diabetes;   Cystic Fibrosis
Intervention:
2 Recruiting Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis
Conditions: Cystic Fibrosis;   Diabetes Related Cystic Fibrosis
Intervention: Procedure: Combined pancreatic islet and lung transplantation
3 Recruiting Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes
Conditions: Cystic Fibrosis;   Cystic Fibrosis Related Diabetes
Interventions: Other: Oral Glucose Tolerance Test;   Other: Mixed Meal Tolerance Test;   Other: Hypoglycemic Clamp
4 Unknown  Ghrelin in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Biological: ghrelin
5 Recruiting Cystic Fibrosis Related Bone Disease: the Role of CFTR
Condition: Cystic Fibrosis Related Bone Disease
Intervention:
6 Not yet recruiting Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention:
7 Not yet recruiting Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients
Conditions: Cystic Fibrosis;   Cystic Fibrosis Pulmonary Exacerbation;   Pseudomonas Aeruginosa Infection
Intervention: Drug: Ceftolozane/Tazobactam
8 Recruiting Cystic Fibrosis- Children and Adults Tai Chi Study
Condition: Cystic Fibrosis
Intervention: Other: Tai chi
9 Not yet recruiting Continuous Glucose Monitoring in Controls With and Without Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
10 Unknown  Transfer Impedance in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
11 Not yet recruiting Cystic Fibrosis (CF) Exacerbation and Insulin Treatment
Conditions: Cystic Fibrosis;   Impaired Glucose Tolerance;   Pulmonary Exacerbation
Interventions: Drug: novorapid / humalog short acting insulin;   Drug: Novo Rapid Insulin (Novonordisk)
12 Unknown  Costimulatory Molecules as Biomarkers in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
13 Not yet recruiting Pulmozyme in Cystic Fibrosis With Sinusitis
Conditions: Sinusitis;   Cystic Fibrosis
Interventions: Drug: Pulmozyme single use ampule;   Drug: placebo
14 Recruiting Gender Disparity and Hormones in Cystic Fibrosis
Condition: Cystic Fibrosis (CF)
Intervention: Drug: Loestrin (norethindrone acetate and ethinyl estradiol)
15 Recruiting Prevention of Cystic Fibrosis Diabetes
Conditions: Cystic Fibrosis;   Prediabetes
Intervention: Drug: Sitagliptin
16 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
17 Not yet recruiting Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences
Condition: Cystic Fibrosis
Interventions: Device: MR measurements of lung morphological changes in cystic fibrosis (Avanto dot, Siemens);   Device: CT measurements of lung morphological changes in cystic fibrosis
18 Unknown  Omega 3 Supplementation in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Dietary Supplement: omega-3 triglycerides;   Dietary Supplement: Placebo
19 Recruiting Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Conditions: Cystic Fibrosis;   Respiratory Tract Infections
Intervention: Dietary Supplement: Cholecalciferol
20 Recruiting Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention: Drug: ivacaftor

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years